<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>INSTI &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/insti/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 17 Oct 2026 22:39:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>INSTI &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Early Treatment Failure Signals: One in 15 HIV Patients in Hubei Miss Viral Suppression at 24 Weeks</title>
		<link>https://bioengineer.org/early-treatment-failure-signals-one-in-15-hiv-patients-in-hubei-miss-viral-suppression-at-24-weeks/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 22:39:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antiretroviral therapy]]></category>
		<category><![CDATA[CD4 count]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cohort Study]]></category>
		<category><![CDATA[Hiv]]></category>
		<category><![CDATA[INSTI]]></category>
		<category><![CDATA[NNRTI]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Treatment adherence]]></category>
		<category><![CDATA[viral load]]></category>
		<category><![CDATA[viral suppression]]></category>
		<category><![CDATA[virological non-suppression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=432951</guid>

					<description><![CDATA[A retrospective cohort study of 4,535 treatment-naive people living with HIV in Hubei, China found that 6.81 percent failed to achieve virological suppression at 24 weeks after starting antiretroviral therapy, with higher baseline viral load, lower CD4 counts, illicit drug use, and NNRTI-based regimens identified as key risk factors.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">432951</post-id>	</item>
	</channel>
</rss>
